Cytosorbents top shareholders
WebMar 9, 2024 · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... Web1 day ago · The investment firm has sold $7.2 billion worth of TCEHY as of January. TCEHY stock is up by about 1.5% year-to-date. Source: StreetVJ / Shutterstock.com. Shares of …
Cytosorbents top shareholders
Did you know?
WebApr 29, 2024 · CytoSorbents Contact: Amy Vogel Investor Relations (732) 398-5394 [email protected] Investor Relations Contact: Jeremy Feffer LifeSci Advisors (212) 915-2568 [email protected]... WebApr 7, 2024 · Cytosorbents Corp’s trailing 12-month revenue is $36.1 million with a -114.6% profit margin. Year-over-year quarterly sales growth most recently was -17.3%. Analysts expect adjusted earnings to reach $-0.374 per share for the current fiscal year. Cytosorbents Corp does not currently pay a dividend. There is a positive fundamental …
WebCytosorbents Corp annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. WebApr 12, 2024 · Cytosorbents issued an update on its fourth quarter 2024 earnings guidance on Tuesday, January, 31st. The company provided earnings per share guidance of for …
Web22 hours ago · By Colin Kellaher. April 13, 2024 10:04 am ET. Text. Groupon Inc. on Thursday said it named Jiri Ponrt as its chief financial officer, as the biggest shareholder … WebOver the past 12 years, Dr. Chan has led the company through the E.U. approval and commercialization of its flagship product, CytoSorb, as a novel blood purification therapy to treat cytokine storm and control deadly …
WebFeb 24, 2024 · Feb. 24, 2024, 07:00 AM. MONMOUTH JUNCTION, N.J., Feb. 24, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive ...
WebOct 14, 2024 · Top Stories. Stock Market. Commodities Market. Rural News. Industries . Basic Materials. ... We regret to report that long term Cytosorbents Corporation (NASDAQ:CTSO) shareholders have had that experience, with the share price dropping 44% in three years, versus a market return of about 66%. The more recent news is of … daisy\\u0027s themeWebSep 4, 2024 · Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Cytosorbents Corporation (NASDAQ:CTSO) share price is up 80% in the ... biotechne wallingford ctWebCytoSorbents operates through its wholly-owned subsidiary, CytoSorbents Medical Inc. (fka CytoSorbents Inc.), and conducts its European business through its wholly-owned subsidiary, CytoSorbents Europe GmbH, with daughter subsidiaries in the United Kingdom, Switzerland, and Poland. daisy\\u0027s third eyeWeb23 hours ago · April 13, 2024 09:14 AM updated an hour ago. Reuters. MILAN - Stellantis shareholders on Thursday approved the compensation package for the car maker's top … biotechne wilson wolfWebApr 3, 2024 · CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its polymer adsorption technology. Its lead product, CytoSorb, is an extracorporeal cytokine … daisy\\u0027s thrift store bruno mnWeb1 day ago · MILAN, April 13 (Reuters) - Stellantis (STLAM.MI) shareholders on Thursday approved the compensation package for the carmaker's top management, including for … daisy\u0027s third eyeWebNov 4, 2024 · CytoSorbents is conducting its pivotal REFRESH 2-AKI trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart ... daisy\\u0027s thorndon